glutathione moa Exploiting phenotypic heterogeneity to improve production of by yeast | Microbial Cell Factories Changsha Huir Biological-tech Co., Ltd
Description
1000 mg/day, P.O for 12 weeks) in patients with CHD [189, 190]
it is not available through the NHS or any regulated UK pharmacy and remains in clinical development
Reference lists were also examined for any additional relevant studies not identified through the search
The human multidrug resistance-associated protein functionally complements the yeast cadmium resistance factor
